基本信息
浏览量:95
职业迁徙
个人简介
I am a biochemist committed to understanding the causes and improving the treatment of schizophrenia, major depressive disorders and bipolar disorder. My research utilises a unique collection of postmortem tissue from subjects with psychiatric disorders to understand how changes in cell biology can bring about the symptoms of psychiatric disorders. I study cell markers in this CNS tissue as the first step in identifying changes in cellular function in the brains of people with psychiatric illness because cell function governs brain function.
My research shows that neurodevelopment and neuroinflammation have key causative roles for disorders such as schizophrenia, major depressive disorders and bipolar disorder. Some of my research is now moving into the clinic, particularly focussing on developing blood based diagnostic tests for schizophrenia and bipolar disorder. My 20 years of research on the role of muscarinic M1 receptor as a cause and site at which to treat schizophrenia is now increasingly recognised as significant because drugs that target that receptor are close to being trialled in subjects with schizophrenia.
My current research focusses are:
Develop blood tests to aid in the clinical management of subjects with psychiatric disorders at the level of diagnostics, theranostics and clinical course.
Using high-throughput screening of the transcriptome and proteome to gain an increased understanding of the causes of psychiatric disorders as a first step in identifying new drug targets that can be used to control the symptoms of people with psychiatric disorders.
Combining genetics, epigenetics, gene expression and neuroimaging to better understand how genes and the environment can affect brain function to cause the changes in function that brings about the symptoms of psychiatric disorders.
My research shows that neurodevelopment and neuroinflammation have key causative roles for disorders such as schizophrenia, major depressive disorders and bipolar disorder. Some of my research is now moving into the clinic, particularly focussing on developing blood based diagnostic tests for schizophrenia and bipolar disorder. My 20 years of research on the role of muscarinic M1 receptor as a cause and site at which to treat schizophrenia is now increasingly recognised as significant because drugs that target that receptor are close to being trialled in subjects with schizophrenia.
My current research focusses are:
Develop blood tests to aid in the clinical management of subjects with psychiatric disorders at the level of diagnostics, theranostics and clinical course.
Using high-throughput screening of the transcriptome and proteome to gain an increased understanding of the causes of psychiatric disorders as a first step in identifying new drug targets that can be used to control the symptoms of people with psychiatric disorders.
Combining genetics, epigenetics, gene expression and neuroimaging to better understand how genes and the environment can affect brain function to cause the changes in function that brings about the symptoms of psychiatric disorders.
研究兴趣
论文共 449 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRYno. 3 (2024): 200-213
Psychiatry Research (2024): 115656-115656
Frontiers in cellular neuroscience (2023): 1232677
引用0浏览0WOS引用
0
0
Neuroscience Applied (2023): 101015-101015
Frontiers in cellular neuroscience (2023): 1124333
EXPERT OPINION ON INVESTIGATIONAL DRUGSno. 12 (2023): 1113-1121
Natalie Matosin,Janine Arloth,Darina Czamara, Katrina Z. Edmond,Malosree Maitra, Anna S. Fröhlich,Silvia Martinelli,Dominic Kaul,Rachael Bartlett,Amber R. Curry,Nils C. Gassen,Kathrin Hafner,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn